Which condition is NOT a contraindication for spiral electrode use?

Which condition is NOT a contraindication for spiral electrode use?

• A. Uncontrolled diabetes
• B. Placenta previa
• C. Face presentation
• D. Fetal thrombocytopenia

Answer: (A)

The condition that is not a contraindication for the use of a spiral electrode is uncontrolled diabetes. In fetal health surveillance, a spiral electrode is used to obtain continuous fetal heart rate monitoring, especially in situations where external monitoring might not provide clear data, such as in the case of obesity or significant maternal movement. Uncontrolled diabetes can pose risks during delivery, but it does not directly interfere with the safe application of a spiral electrode. The electrode is placed directly onto the fetal scalp, which is a localized procedure; thus, the presence of diabetes itself is not a factor that would prevent the use of this monitoring method. In contrast, other conditions like placenta previa, face presentation, and fetal thrombocytopenia present more significant risks during labor and delivery that can influence the decision to use invasive monitoring techniques. Placenta previa raises concerns about potential bleeding, face presentation may complicate delivery, and fetal thrombocytopenia could lead to increased bleeding risks for the fetus. Therefore, while managing maternal diabetes is important, it does not serve as a contraindication to spiral electrode use.

The condition that is not a contraindication for the use of a spiral electrode is uncontrolled diabetes. In fetal health surveillance, a spiral electrode is used to obtain continuous fetal heart rate monitoring, especially in situations where external monitoring might not provide clear data, such as in the case of obesity or significant maternal movement.

Uncontrolled diabetes can pose risks during delivery, but it does not directly interfere with the safe application of a spiral electrode. The electrode is placed directly onto the fetal scalp, which is a localized procedure; thus, the presence of diabetes itself is not a factor that would prevent the use of this monitoring method.

In contrast, other conditions like placenta previa, face presentation, and fetal thrombocytopenia present more significant risks during labor and delivery that can influence the decision to use invasive monitoring techniques. Placenta previa raises concerns about potential bleeding, face presentation may complicate delivery, and fetal thrombocytopenia could lead to increased bleeding risks for the fetus. Therefore, while managing maternal diabetes is important, it does not serve as a contraindication to spiral electrode use.